MedPath

The efficacy of triple standard therapy for Helicobacter pylori eradication in diabetic patients

Not Applicable
Recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0001062
Lead Sponsor
Kangwon National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
360
Inclusion Criteria

1. adult patients(18 years of age or older) who had peptic ulcer disease with Helicobacter pylori infection
2. participants obtained written informed consent

Exclusion Criteria

1. diagnosis of malignancy
2. pregnancy
3. prior H. pylori eradication therapy
4. use antibiotics in the preceding 3 months
5. history of gastric surgery
6. refusal or contraindication of endoscopy
7. history of drug adverse event or allergy

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori eradication rate;correlation between hlicobacter pylori eradication rate and HbA1c or microangiopathy
Secondary Outcome Measures
NameTimeMethod
drug adverse event and compliance
© Copyright 2025. All Rights Reserved by MedPath